The E.G7-OVA is a mouse lymphoma cell line derived by the electroporation of EL4 cells with a plasmid which carries a complete copy of chicken ovalbumin (OVA) mRNA. These cells synthesize and secrete OVA constitutively. C57BL/6N mice immunized with E.G7-OVA cells generate H-2Kb restricted cytotoxic lymphocytes specific for the OVA258-276 peptide(1). This model serves as a useful tool for the study of cancer immunology. At CrownBio, the E.G7-OVA model is available as both subcutaneous and systemic (i.v. injected) models. EL4, the parental model, is also available.
Response to Immune Checkpoint Inhibitors
(1) Moore MW, et al. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54: 777-785, 1988.